an anesthesia services company, Aetna in July announced that it was suspending its plan to cut reimbursement for monitored anesthesia care
during routine colonoscopies and esophagogastroduodenoscopies.
These patients may be better suited for the operating room under monitored anesthesia care
Decision on Monitored Anesthesia Care
Seeks to Avoid Impact on Colon Cancer Screening Rates, Provides Transition to Patient-Friendly Alternatives in Emerging New Sedation Approaches
The company currently markets DIPRIVAN(R) (propofol) Injectable Emulsion, a sedative hypnotic for the induction and maintenance of anesthesia and monitored anesthesia care
, and recently submitted regulatory packages in the US and UK for SEROQUEL(TM) (quetiapine), a new oral atypical antipsychotic medication discovered and developed by Zeneca Pharmaceuticals for the management of the manifestations of psychotic disorders.